Dr. Newman on Health Disparities in Breast Cancer

Video

In Partnership With:

Lisa Newman, MD, MPH, FACS, FASCO, chief of Breast Surgery, Weill Cornell Medical Center and NewYork-Presbyterian, discusses health disparities among women with breast cancer.

Lisa Newman, MD, MPH, FACS, FASCO, chief of Breast Surgery, Weill Cornell Medical Center and NewYork-Presbyterian, discusses health disparities among women with breast cancer.

Much of the research regarding health disparities has been done in African-American and Caucasian patients as that is where the biggest differential is, says Newman. Specifically, in breast cancer, higher disease-specific mortality is seen in African Americans than in Caucasians. Additionally, a higher proportion of breast cancer cases are diagnosed in younger women in the African-American community than in the Caucasian community, she adds. More concerningly is the higher degree to which biologically aggressive cancers manifest in African Americans than in Caucasians. Triple-negative breast cancers are twice as common among African-American women than in Caucasian women.

There are several reasons for these disparities, explains Newman. For example, socioeconomic disadvantages among the African-American community, which hinder their ability to access adequate healthcare coverage. This in turn can delay the time to diagnosis, which may explain why these patients present with more advanced-stage disease. The patterns regarding younger age and more aggressive disease among these patients are more likely related to tumor biology and genetics, says Newman.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Video 1 - "HR+/HER2- Early-Stage Breast Cancer: Background and Risk Stratification "